Brainsway Files Routine 6-K Report on March 26, 2026
Ticker: BWAY · Form: 6-K · Filed: Mar 26, 2026 · CIK: 0001505065
| Field | Detail |
|---|---|
| Company | Brainsway Ltd. (BWAY) |
| Form Type | 6-K |
| Filed Date | Mar 26, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $6 Million |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing, procedural-update
TL;DR
**Brainsway filed a routine 6-K, likely a procedural update with no immediate news.**
AI Summary
Brainsway Ltd. filed a 6-K on March 26, 2026, indicating a routine report for foreign issuers. This filing includes the main 6-K document and an exhibit, likely a press release, given the 'EX-99.1' designation. For investors, this filing itself doesn't contain new financial or operational news but serves as a procedural update, meaning no immediate impact on stock value is expected unless the attached exhibit contains significant information.
Why It Matters
This filing is a standard procedural update for foreign companies and does not inherently contain new material information unless the attached exhibit details a significant event.
Risk Assessment
Risk Level: low — This 6-K filing is a standard report for foreign issuers and does not, by itself, indicate any new financial or operational risks.
Analyst Insight
Investors should review the EX-99.1 exhibit to determine if any material information was disclosed, as the 6-K itself is a procedural filing.
Key Numbers
- 2026-03-26 — Filing Date (The date the 6-K report was filed by Brainsway Ltd.)
- 2 — Number of Documents (The total number of documents included in this 6-K filing.)
- 5317 — Size of FORM 6-K (The size in bytes of the main 6-K document (f6k_032526.htm).)
- 9748 — Size of EX-99.1 (The size in bytes of the exhibit document (exh_991.htm), likely a press release.)
Key Players & Entities
- Brainsway Ltd. (company) — the filer of the 6-K report
- 0001505065 (company) — CIK of Brainsway Ltd.
- 0001171843-26-001925 (dollar_amount) — SEC Accession No. for the filing
Forward-Looking Statements
- The EX-99.1 exhibit will contain a press release. (Brainsway Ltd.) — high confidence, target: 2026-03-26
- This 6-K filing will not contain significant new financial results. (Brainsway Ltd.) — medium confidence, target: 2026-03-26
FAQ
What is the purpose of a 6-K filing for Brainsway Ltd.?
A 6-K filing is a 'Report of foreign issuer' under Rules 13a-16 and 15d-16, used by foreign private issuers like Brainsway Ltd. to report material information to the SEC that is made public in their home country or filed with a foreign stock exchange.
When was this specific 6-K filing submitted and accepted by the SEC?
This 6-K filing was submitted on March 26, 2026, and accepted on the same date at 07:30:04.
How many documents are included in this 6-K submission?
There are two documents included in this submission: the main FORM 6-K (f6k_032526.htm) and an exhibit, EX-99.1 (exh_991.htm), which is typically a press release.
What is Brainsway Ltd.'s CIK number and SIC code?
Brainsway Ltd.'s CIK number is 0001505065, and its SIC code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Where is Brainsway Ltd.'s business address located?
Brainsway Ltd.'s business address is 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, Har HaHotzvim, Jerusalem L3 9777516.
Filing Stats: 229 words · 1 min read · ~1 pages · Grade level 11.6 · Accepted 2026-03-26 07:30:04
Key Financial Figures
- $6 Million — e 99.1 BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief
Filing Documents
- f6k_032526.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 10KB
- 0001171843-26-001925.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BRAINSWAY LTD. (Registrant) Date: March 26, 2026 /s/ Hadar Levy Hadar Levy Chief Executive Officer